BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 24836952)

  • 1. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
    Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
    Tong SW; Xiang B; Dong DW; Qi XR
    Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micelles of enzymatically synthesized PEG-poly(amine-co-ester) block copolymers as pH-responsive nanocarriers for docetaxel delivery.
    Zhang X; Liu B; Yang Z; Zhang C; Li H; Luo X; Luo H; Gao D; Jiang Q; Liu J; Jiang Z
    Colloids Surf B Biointerfaces; 2014 Mar; 115():349-58. PubMed ID: 24398083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel.
    Hami Z; Amini M; Ghazi-Khansari M; Rezayat SM; Gilani K
    Colloids Surf B Biointerfaces; 2014 Apr; 116():309-17. PubMed ID: 24503352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
    Dou J; Zhang H; Liu X; Zhang M; Zhai G
    Colloids Surf B Biointerfaces; 2014 Feb; 114():20-7. PubMed ID: 24157590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
    Yang Y; Wang J; Zhang X; Lu W; Zhang Q
    J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel.
    Gao Y; Ren F; Ding B; Sun N; Liu X; Ding X; Gao S
    J Drug Target; 2011 Aug; 19(7):516-27. PubMed ID: 20883085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
    Xu P; Meng Q; Sun H; Yin Q; Yu H; Zhang Z; Cao M; Zhang Y; Li Y
    Biomaterials; 2015 Sep; 64():10-20. PubMed ID: 26106797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancer.
    Guo Y; He W; Yang S; Zhao D; Li Z; Luan Y
    Colloids Surf B Biointerfaces; 2017 Mar; 151():119-127. PubMed ID: 27988472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.
    Jin MJ; Piao SJ; Jin TX; Jin ZH; Yin XZ; Gao ZG
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):66-75. PubMed ID: 24496681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
    Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
    Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy.
    Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N
    Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment.
    Cho JK; Hong JM; Han T; Yang HK; Song SC
    J Drug Target; 2013 Jul; 21(6):564-73. PubMed ID: 23594096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel.
    Mu CF; Balakrishnan P; Cui FD; Yin YM; Lee YB; Choi HG; Yong CS; Chung SJ; Shim CK; Kim DD
    Biomaterials; 2010 Mar; 31(8):2371-9. PubMed ID: 20031202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
    Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
    J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.
    Emami J; Kazemi M; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A
    Pharm Dev Technol; 2020 Apr; 25(4):492-509. PubMed ID: 31903817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.